Pfizer CEO Albert Bourla on Sunday said the vaccine maker plans to submit data on a fourth dose of its COVID-19 vaccine to the U.S. Food and Drug Administration because protection after three doses is “not that good against infections” and “doesn’t last very long” when faced with a variant like Omicron.
The Biden administration made direct payments to nearly all major corporate media outlets to deploy a $1 billion taxpayer-funded outreach campaign designed to push only positive coverage about COVID-19 vaccines and to censor any negative coverage, according to documents obtained by The Blaze.
A recent study of more than a million children shows that Pfizer's mRNA COVID-19 vaccine has negative efficacy for the youngest children it’s recommended for.
A family whose 21-year-old son developed a life-threatening reaction to Pfizer’s COVID vaccine has been waiting six months to learn if the U.S. government’s Countermeasures Injury Compensation Program will help cover their son’s medical bills, but there’s been no response from the program.
The Joint Committee on Vaccination and Immunization (JCVI), an independent group of experts who advise the UK’s government health departments on immunizations published a report on 16 February stating, ‘JCVI advises a non-urgent offer at two 10mcg doses of the Pfizer-BioNTech Covid-19 vaccine to children aged 5 to 11 years of age who are not in a clinical risk group.’
